D2: 7 Key Factors Impacting Value-Based Contracting Between Plans/PBMs and Pharma or Medical Device Manufacturers

1. New, emerging technologies without competitive threats should provide data and enable a “little educated risk” to achieve better payer coverage and long term growth with value-based contracts.
2. To reduce risk, develop a deep understanding and insights on how payers are using analytics or reporting related to value based contracting.
3. Understand how new payment models for payers and providers are impacting the way manufacturers need to approach pricing, contracting and patient support services.
4. Identify realistic, actionable yearly data metrics or supplemental data captured by technologies in contracting arrangements.
5. Analyze, differentiate a new business model to get a seat at the table and successfully interact with a payer’s expectations for value-based arrangements.
6. Be prepared to discuss “overpriced specialty drugs” and value-based contracting coverage.
7. Align incentives between manufacturers and payers to best drive appropriate patient outcomes.

Source: D2 Consulting
Source URL: https://www.businesswire.com/news/home/20180717005077/en

Printer-friendly versionSend to friendmore...